Cargando…
Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics
Autores principales: | Li, Zijie, Ji, Wangquan, Chen, Shuaiyin, Duan, Guangcai, Jin, Yuefei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054684/ https://www.ncbi.nlm.nih.gov/pubmed/36992155 http://dx.doi.org/10.3390/vaccines11030571 |
Ejemplares similares
-
Current status of hand-foot-and-mouth disease
por: Zhu, Peiyu, et al.
Publicado: (2023) -
Arising Concerns of Atypical Manifestations in Patients with Hand, Foot, and Mouth Disease
por: Chen, Yu, et al.
Publicado: (2023) -
Laboratory Indicators for Identifying Hand, Foot, and Mouth Disease Severity: A Systematic Review and Meta-Analysis
por: Xie, Yaqi, et al.
Publicado: (2022) -
A mouse model and pathogenesis study for CVA19 first isolated from hand, foot, and mouth disease
por: Ji, Wangquan, et al.
Publicado: (2023) -
Involvement of the renin-angiotensin system in the progression of severe hand-foot-and-mouth disease
por: Zhang, Chao, et al.
Publicado: (2018)